Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Motor Activity 1 Leukemia 1 Infections 1 Genital Neoplasms, Female 1 Endometrial Neoplasms 1

Interventions

Dexamethasone 28 Rituximab 16 pomalidomide 13 Gemcitabine 12 Lenalidomide 11 Cisplatin 11 Bortezomib 11 Paclitaxel 10 Cyclophosphamide 8 Carboplatin 8 carfilzomib 7 selinexor 5 daratumumab 5 Drug Therapy 5 Doxorubicin 5 Cytarabine 5 ibrutinib 4 Vincristine 4 Temozolomide 4 Prednisone 4 Docetaxel 4 Calcium Dobesilate 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 Cetuximab 3 Bendamustine Hydrochloride 3 venetoclax 2 ofatumumab 2 galiximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × Diet × Clear all

NCT02035631 2014-01-14

PREDICOP

Institut Català d'Oncologia

Phase 3 Unknown

Breast Neoplasms, Motor Activity, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡